Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
Download
Download
Download![[img]](/style/images/fileicons/text.png)
Timpani et al_Orphanet J Rare Diseases_2017.pdf
- Published Version
(639kB)
Available under license: Creative Commons Attribution
Export
Timpani, Cara 
ORCID: 0000-0003-4567-4319, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036
(2017)
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
Orphanet Journal of Rare Diseases, 12 (1).
100 - 100.
ISSN 1750-1172
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/33704 |
| DOI | https://doi.org/10.1186/s13023-017-0652-y |
| Official URL | https://ojrd.biomedcentral.com/articles/10.1186/s1... |
| Subjects | Historical > FOR Classification > 1109 Neurosciences Historical > FOR Classification > 1116 Medical Physiology Current > Division/Research > College of Health and Biomedicine |
| Keywords | Clinical trials; Duchenne muscular dystrophy; Neuronal nitric oxide synthase; Nitric oxide; Skeletal muscle; mdx mouse |
| Citations in Scopus | 13 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)